WCM Investment Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
WCM Investment Management's ATRC Position: Q2 2026 in Review
WCM Investment Management reduced its AtriCure (ATRC) stake by 2.4% in Q2 2026, selling an estimated $244K and leaving 351,081 shares worth $10.1M. The position accounts for 0.02% of the portfolio, ranked #157.
WCM Investment Management first reported a position in ATRC in Q1 2019 and has held it in 30 quarters since. The position peaked at $15M in Q4 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- WCM Investment Management held 351,081 shares of AtriCure worth $10.1M as of Q2 2026.
- WCM Investment Management sold 8,680 AtriCure shares in Q2 2026, an estimated $244K.
- AtriCure made up 0.02% of WCM Investment Management's portfolio in Q2 2026, its #157 holding.
- WCM Investment Management first reported a position in AtriCure in Q1 2019 and has held it in 30 quarters since.
- WCM Investment Management's AtriCure position peaked at $15M in Q4 2025.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on WCM Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.